CoreCap Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73K Hold
20
﹤0.01% 2456
2026
Q1
$2.36K Hold
20
﹤0.01% 2374
2025
Q4
$3.28K Buy
+20
New +$3.13K ﹤0.01% 2345
2025
Q2
Sell
-1
Closed -$127 3161
2025
Q1
$127 Buy
+1
New +$154 ﹤0.01% 3042
2022
Q1
Sell
-125
Closed -$33K 1730
2021
Q4
$33K Buy
+125
New +$33.7K ﹤0.01% 1140

Other funds holding RGEN

CoreCap Advisors's RGEN Position: Q2 2026 in Review

CoreCap Advisors held its Repligen (RGEN) position steady in Q2 2026 at 20 shares worth $2.73K. The position accounts for ﹤0.01% of the portfolio, ranked #2456.

CoreCap Advisors first reported a position in RGEN in Q4 2021 and has held it in 5 quarters since. The position peaked at $33K in Q4 2021. 60 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • CoreCap Advisors held 20 shares of Repligen worth $2.73K as of Q2 2026.
  • CoreCap Advisors left its Repligen share count unchanged in Q2 2026.
  • Repligen made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2456 holding.
  • CoreCap Advisors first reported a position in Repligen in Q4 2021 and has held it in 5 quarters since.
  • CoreCap Advisors's Repligen position peaked at $33K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.